Published in J Oral Maxillofac Surg on March 01, 2007
Outcomes in head and neck reconstruction by surgical site and donor site. Laryngoscope (2013) 0.90
Osteoradionecrosis of the mandible: a review. Oral Maxillofac Surg (2012) 0.83
Use of recombinant bone morphogenetic protein 2 in free flap reconstruction for osteonecrosis of the mandible. J Oral Maxillofac Surg (2011) 0.80
Osteoradionecrosis of the jaws--a current overview--Part 2: dental management and therapeutic options for treatment. Oral Maxillofac Surg (2010) 0.78
Management of complications and compromised free flaps following major head and neck surgery. Eur Arch Otorhinolaryngol (2015) 0.77
A head and neck cancer intervention for use in survivorship clinics: a protocol for a feasibility study. Pilot Feasibility Stud (2016) 0.75
Management of venous thrombosis in fibular free osseomusculocutaneous flaps used for mandibular reconstruction: clinical techniques and treatment considerations. Head Face Med (2010) 0.75
Dental status, dental treatment procedures and radiotherapy as risk factors for infected osteoradionecrosis (IORN) in patients with oral cancer - a comparison of two 10 years' observation periods. Springerplus (2014) 0.75
Heterogeneity of Necrotic Changes between Cortical and Cancellous Bone in Mandibular Osteoradionecrosis: A Histopathological Analysis of Resection Margin after Segmental Mandibulectomy. Biomed Res Int (2017) 0.75
Surgical outcome and prognostic factors after treatment of osteoradionecrosis of the jaws. J Cancer Res Clin Oncol (2012) 0.75
Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer (2005) 3.27
The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags. Proc Natl Acad Sci U S A (2003) 1.79
Cytokeratin expression in central mucoepidermoid carcinoma and glandular odontogenic cyst. Oral Oncol (2004) 1.69
Pectoralis major and other myofascial/myocutaneous flaps in head and neck cancer reconstruction: experience with 437 cases at a single institution. Head Neck (2004) 1.66
Comparison of two prognostic scores for patients with parotid carcinoma. Head Neck (2009) 1.55
Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: Report of 3 cases. J Oral Maxillofac Surg (2007) 1.50
Large-scale transcriptome analyses reveal new genetic marker candidates of head, neck, and thyroid cancer. Cancer Res (2005) 1.47
Oral myofibromas: report of two cases and review of clinical and histopathologic differential diagnosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2008) 1.30
Cutaneous angiosarcoma of the head and neck: report of 23 cases from a single institution. Otolaryngol Head Neck Surg (2008) 1.28
Prognostic factors in head and neck mucoepidermoid carcinoma. Arch Otolaryngol Head Neck Surg (2004) 1.23
Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer. Head Neck (2010) 1.22
Prognostic factors in head and neck adenoid cystic carcinoma. Oral Oncol (2005) 1.22
Risk factors for stomach cancer in Brazil (I): a case-control study among non-Japanese Brazilians in São Paulo. Jpn J Clin Oncol (2002) 1.22
Salivary gland tumors in children and adolescents: a clinicopathologic and immunohistochemical study of fifty-three cases. Int J Pediatr Otorhinolaryngol (2004) 1.21
Clinicopathological and immunohistochemical analysis of twenty-five head and neck osteosarcomas. Oral Oncol (2003) 1.21
Surgical complications after thyroid surgery performed in a cancer hospital. Otolaryngol Head Neck Surg (2005) 1.20
Oral verrucous carcinoma: a retrospective study in São Paulo Region, Brazil. Clin Oral Investig (2006) 1.20
Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth. Oral Oncol (2004) 1.20
Voice and swallowing in patients enrolled in a larynx preservation trial. Arch Otolaryngol Head Neck Surg (2003) 1.19
Risk factors for stomach cancer in Brazil (II): a case-control study among Japanese Brazilians in São Paulo. Jpn J Clin Oncol (2002) 1.19
Giant pleomorphic adenoma of the parotid gland. Med Oral Patol Oral Cir Bucal (2008) 1.13
Comorbidity is a prognostic factor in elderly patients with head and neck cancer. Ann Surg Oncol (2007) 1.11
Histologic subtypes of oral squamous cell carcinoma: prognostic relevance. J Can Dent Assoc (2007) 1.11
Predictive factors and distribution of lymph node metastasis in lip cancer patients and their implications on the treatment of the neck. Oral Oncol (2004) 1.09
Prognoses of oral basaloid squamous cell carcinoma and squamous cell carcinoma: a comparison. Arch Otolaryngol Head Neck Surg (2004) 1.09
Adenoid cystic carcinoma and mucoepidermoid carcinoma of the maxillary sinus: report of a 44-year experience of 25 cases from a single institution. J Oral Maxillofac Surg (2006) 1.08
Nonlymphoid mesenchymal tumors of the parotid gland. Oral Oncol (2008) 1.07
Clinical predictors of quality of life in patients with initial differentiated thyroid cancers. Arch Otolaryngol Head Neck Surg (2009) 1.04
Multiple granular cell tumors of the tongue and parotid gland. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2009) 1.04
Rhabdomyosarcoma of the head and neck: a clinicopathological and immunohistochemical analysis of 29 cases. Braz Dent J (2010) 1.02
Bisphosphonate-related osteonecrosis of the jaws--an initial case series report of treatment combining partial bone resection and autologous platelet-rich plasma. J Oral Maxillofac Surg (2011) 1.01
Plasmacytoid myoepithelioma of the palate in a child. Int J Paediatr Dent (2007) 1.01
Tissue eosinophilia and its association with tumoral invasion of oral cancer. Int J Surg Pathol (2009) 1.00
HOXA1 is overexpressed in oral squamous cell carcinomas and its expression is correlated with poor prognosis. BMC Cancer (2012) 0.99
Papillary squamous cell carcinoma of the tongue. Otolaryngol Head Neck Surg (2009) 0.98
Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer. Head Neck (2006) 0.97
Perioperative complications, comorbidities, and survival in oral or oropharyngeal cancer. Arch Otolaryngol Head Neck Surg (2003) 0.97
Quality of life related to swallowing after tongue cancer treatment. Dysphagia (2007) 0.97
Clinicopathological significance of ubiquitin-specific protease 2a (USP2a), fatty acid synthase (FASN), and ErbB2 expression in oral squamous cell carcinomas. Oral Oncol (2009) 0.97
The role of eosinophils and eosinophil cationic protein in oral cancer: a review. Arch Oral Biol (2010) 0.96
Voice and vocal self-assessment after thyroidectomy. Head Neck (2006) 0.96
CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients. Oral Oncol (2009) 0.95
Postoperative complications of thyroidectomy for differentiated thyroid carcinoma. Am J Otolaryngol (2004) 0.94
Distribution of metastatic lymph nodes in oropharyngeal carcinoma and its implications for the elective treatment of the neck. Arch Otolaryngol Head Neck Surg (2003) 0.93
Recurrent oral cancer: current and emerging therapeutic approaches. Front Pharmacol (2012) 0.93
Clinicopathological and immunohistochemical evaluation of oral squamous cell carcinoma in patients with early local recurrence. Oral Oncol (2006) 0.93
Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients. Oral Oncol (2011) 0.93
Distinct regions of loss of heterozygosity on 22q in different sites of head and neck squamous cell carcinomas. Med Sci Monit (2002) 0.92
TIMP3 and CCNA1 hypermethylation in HNSCC is associated with an increased incidence of second primary tumors. J Transl Med (2013) 0.92
High-risk human papillomavirus in oral squamous cell carcinoma of young patients. Int J Cancer (2011) 0.92
CCND1 amplification and protein overexpression in oral squamous cell carcinoma of young patients. Head Neck (2011) 0.92
Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer. Br J Clin Pharmacol (2014) 0.92
Surgical treatment of paragangliomas of the carotid bifurcation: results of 36 patients. Head Neck (2004) 0.92
Risk factors for surgical-site infections in head and neck cancer surgery. Otolaryngol Head Neck Surg (2008) 0.92
Prevalence of upper aerodigestive symptoms in patients who underwent thyroidectomy with and without the use of intraoperative laryngeal nerve monitoring. Thyroid (2012) 0.92
Head and neck chondrosarcoma: analysis of 16 cases. Br J Oral Maxillofac Surg (2009) 0.91
For early-stage oral tongue cancer, depth of invasion and worst pattern of invasion are the strongest pathological predictors for locoregional recurrence and mortality. Virchows Arch (2015) 0.91
Comparative cytokeratin expression in the different cell types of salivary gland mucoepidermoid carcinoma. Head Neck Pathol (2008) 0.90
Dietary patterns and risk of oral cancer: a case-control study in São Paulo, Brazil. Rev Saude Publica (2007) 0.90
Long-term quality-of-life evaluation after head and neck cancer treatment in a developing country. Arch Otolaryngol Head Neck Surg (2004) 0.90
Candida oral colonization and infection in Brazilian patients undergoing head and neck radiotherapy: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2006) 0.90
Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection. Cancer Causes Control (2014) 0.89
Validation of the Washington University Head and Neck Comorbidity Index in a cohort of older patients. Arch Otolaryngol Head Neck Surg (2008) 0.89
Identification of upregulated genes in oral squamous cell carcinomas. Head Neck (2012) 0.89
Parotid neoplasms: analysis of 600 patients attended at a single institution. Braz J Otorhinolaryngol (2009) 0.88
Brazilian-Portuguese validation of the University of Washington Quality of Life Questionnaire for patients with head and neck cancer. Head Neck (2006) 0.88
Factors that influence treatment decision in older patients with resectable head and neck cancer. Laryngoscope (2007) 0.88
TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target. Cancer (2013) 0.88
Estrogen receptor expression in salivary gland mucoepidermoid carcinoma and adenoid cystic carcinoma. Pathol Oncol Res (2004) 0.88
HOXB7 expression is a prognostic factor for oral squamous cell carcinoma. Histopathology (2012) 0.88
Validation and application of the M.D. Anderson Dysphagia Inventory in patients treated for head and neck cancer in Brazil. Dysphagia (2012) 0.87
Biological markers and prognosis in recurrent oral cancer after salvage surgery. Arch Otolaryngol Head Neck Surg (2008) 0.87
Prognostic significance of TIMP3 hypermethylation in post-treatment salivary rinse from head and neck squamous cell carcinoma patients. Carcinogenesis (2012) 0.86
Second primary tumors in patients with head and neck cancer. Curr Oncol Rep (2011) 0.86
Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma. Clin Exp Metastasis (2014) 0.86
Clinicopathologic and immunohistochemical study of intraoral mucoepidermoid carcinoma. Otolaryngol Head Neck Surg (2006) 0.86
Caspase expression in oral squamous cell carcinoma. Head Neck (2010) 0.86
APACHE II, POSSUM, and ASA scores and the risk of perioperative complications in patients with oral or oropharyngeal cancer. Arch Otolaryngol Head Neck Surg (2003) 0.86
Mammary analogue secretory carcinoma of salivary glands is a lipid-rich tumour, and adipophilin can be valuable in its identification. Histopathology (2013) 0.86
Metastatic renal cell carcinoma to the oral cavity and clear cell mucoepidermoid carcinoma: comparative clinicopathologic and immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2010) 0.85
Expression of Bcl-2 family proteins and association with clinicopathological characteristics of oral squamous cell carcinoma. Histopathology (2010) 0.85
Nucleophosmin, p53, and Ki-67 expression patterns on an oral squamous cell carcinoma tissue microarray. Hum Pathol (2010) 0.85
Podoplanin and VEGF-C immunoexpression in oral squamous cell carcinomas: prognostic significance. Anticancer Res (2013) 0.84
Claudin-7 down-regulation is an important feature in oral squamous cell carcinoma. Histopathology (2010) 0.84
Prognostic significance of beta-2 adrenergic receptor in oral squamous cell carcinoma. Cancer Biomark (2012) 0.83
Dedifferentiated liposarcoma of the oral cavity with angiosarcomatous dedifferentiation. Virchows Arch (2005) 0.83
Socioeconomic effects of and risk factors for disability in long-term survivors of head and neck cancer. Arch Otolaryngol Head Neck Surg (2006) 0.83
Second primary tumor in patients with upper aerodigestive tract cancer. Braz J Otorhinolaryngol (2010) 0.82
Classic and molecular cytogenetic analyses reveal chromosomal gains and losses correlated with survival in head and neck cancer patients. Clin Cancer Res (2005) 0.82
Relationship between major and minor salivary gland mucoepidermoid carcinoma malignancy grading and presence of stromal myofibroblasts: immunohistochemical study. J Oral Pathol Med (2004) 0.81
H19-DMR allele-specific methylation analysis reveals epigenetic heterogeneity of CTCF binding site 6 but not of site 5 in head-and-neck carcinomas: a pilot case-control analysis. Int J Mol Med (2006) 0.81
Acceptance of major surgical procedures and quality of life among long-term survivors of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg (2009) 0.81
Activin A immunoexpression as predictor of occult lymph node metastasis and overall survival in oral tongue squamous cell carcinoma. Head Neck (2014) 0.81
Second salvage surgery for re-recurrent oral cavity and oropharynx carcinoma. Head Neck (2010) 0.81
Sublingual salivary gland tumors: clinicopathologic study of six cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2005) 0.80
Case-control study on prognostic factors in oral squamous cell carcinoma in young patients. Head Neck (2010) 0.80
Expression of PAR-4 and PHLDA1 is prognostic for overall and disease-free survival in oral squamous cell carcinomas. Virchows Arch (2013) 0.80
Mel-CAM (CD146) expression in parotid mucoepidermoid carcinoma. Oral Oncol (2003) 0.80